Rohitas Deshmukh

Papers

Total Citations

H-Index

About

Rohitas Deshmukh is a pioneering researcher at the forefront of nanomedicine, with a specialized focus on the development and application of DNA nanobots for oncology and pharmaceutical delivery. His major contributions lie in conceptualizing how these programmable, biocompatible nanostructures can revolutionize cancer treatment by offering a targeted alternative to conventional chemotherapy and radiation, thereby minimizing severe side effects. His most-cited work, "DNA Nanobots – Emerging Customized Nanomedicine in Oncology" (2022), has garnered 23 citations, establishing a foundational framework for using DNA-based robots as precise, customizable therapeutic agents against one of the twenty-first century’s most lethal diseases. In his subsequent 2024 paper, "Nanobots: A Revolutionary Technology in the Development of Pharmaceuticals," Deshmukh expands this vision, exploring how nanobots can transform broader pharmaceutical development. Through his research, Deshmukh is helping to bridge the gap between molecular engineering and clinical medicine, positioning DNA nanobots as a revolutionary tool for personalized, non-invasive cancer care. His work continues to inspire new directions in targeted drug delivery and smart therapeutics.